GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Anthera Pharmaceuticals, Inc. (ANTH) [hlAlert]

Anthera Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on developing and commercializing therapeutics to treat diseases associated with inflammation, including cardiovascular and autoimmune diseases. Its primary product candidates include varespladib methyl (A-002), which has completed its Phase 2 clinical studies for the treatment of acute coronary
syndrome; varespladib sodium (A-001) that is in a Phase 2 clinical study for the prevention of acute chest syndrome associated with sickle cell disease; and A-623, which has completed Phase 1 clinical studies for the treatment of B-cell mediated autoimmune diseases. The company has license agreements with Eli Lilly and Company, and Shionogi & Co., Ltd. to develop and commercialize secretory phospholipase A2 or sPLA2 inhibitors for the treatment of cardiovascular disease and other diseases; and Amgen Inc., to develop and commercialize A-623. Anthera Pharmaceuticals, Inc. was founded in 2004 and is headquartered in Hayward, California.
( Total: 12 Current Stock Recommendations )
Anthera Pharmaceuticals, Inc.   (12)
Hold 25% Buy 75%
Related companies
Show  

Date (ET)MemberRatingYTD
Gains
 
10/20/2010  
Buy
  
8/1/2011  
Hold
  
11/1/2011  
Buy
  
12/2/2011  
Buy
  
3/12/2012  
Buy
  
4/26/2012  
Buy
  
4/26/2012  
Buy
  
6/28/2012  
Hold
  
6/29/2012  
Hold
  
11/13/2012  
Buy
  
3/5/2013  
Buy
  
9/17/2015  
Buy
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy